Chinese Vice President Han Zheng meets with Helge Lund, chair of the board of directors of Novo Nordisk, in Beijing, capital of China, Aug. 20, 2025. (Xinhua/Pang Xinglei)
BEIJING, Aug. 20 (Xinhua) -- Global biomedical companies, including Novo Nordisk, are welcome to step up cooperation with China, Chinese Vice President Han Zheng said on Wednesday when meeting with Helge Lund, chair of the company's board of directors.
By continuously deepening its reform and expanding its high-level opening-up, China will provide huge development opportunities for enterprises from all over the world, including Novo Nordisk, Han said.
China prioritizes its people's health. It has built the world's largest basic health care insurance network and its average life expectancy continues to rise, Han said, welcoming Novo Nordisk and other leading biomedical companies to step up cooperation with China.
Lund spoke highly of the achievements China's economic and social development has seen in recent years, stating that the company will cultivate the Chinese market further, expand investment in China and achieve win-win results.
Chinese Vice President Han Zheng meets with Helge Lund, chair of the board of directors of Novo Nordisk, in Beijing, capital of China, Aug. 20, 2025. (Xinhua/Pang Xinglei)
A single purchase
